Literature DB >> 4131473

Letter: Hypersecretion of calcitonin in neoplastic conditions.

G Milhaud, C Calmette, J Taboulet, A Julienne, M S Moukhtar.   

Abstract

Mesh：

Substances：

Year:  1974        PMID： 4131473     DOI： 10.1016/s0140-6736(74)92428-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  20 in total

Review 1.  Cell differentiation and the biological significance of inappropriate tumour products.

Authors:  M L Ellison
Journal:  Proc R Soc Med       Date:  1977-12

2.  Comparison of tumour markers in malignant mesothelioma and pulmonary adenocarcinoma.

Authors:  A R Gibbs; R Harach; J C Wagner; B Jasani
Journal:  Thorax       Date:  1985-02       Impact factor: 9.139

3.  Letter: Serum calcitonin and thyroid carcinoma.

Authors:  P Greenberg; I MacIntyre
Journal:  Br Med J       Date:  1974-07-27

4.  Jejunal fluid and electrolyte secretion in carcinoid syndrome.

Authors:  M Donowitz; H J Binder
Journal:  Am J Dig Dis       Date:  1975-12

5.  Purification and partial characterization of high-molecular-weight forms of ectopic calcitonin from a human bronchial carcinoma cell line.

Authors:  J Lumsden; J Ham; M L Ellison
Journal:  Biochem J       Date:  1980-10-01       Impact factor: 3.857

6.  Tumour calcitonin. Interaction with specific calcitonin receptors.

Authors:  J Ham; M L Ellison; J Lumsden
Journal:  Biochem J       Date:  1980-09-15       Impact factor: 3.857

7.  High serum procalcitonin concentrations in patients with sepsis and infection.

Authors:  M Assicot; D Gendrel; H Carsin; J Raymond; J Guilbaud; C Bohuon
Journal:  Lancet       Date:  1993-02-27       Impact factor: 79.321

8.  Preprocalcitonin signal peptide generates a cytotoxic T lymphocyte-defined tumor epitope processed by a proteasome-independent pathway.

Authors:  Faten El Hage; Vincent Stroobant; Isabelle Vergnon; Jean-François Baurain; Hamid Echchakir; Vladimir Lazar; Salem Chouaib; Pierre G Coulie; Fathia Mami-Chouaib
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-14       Impact factor: 11.205

9.  Prospective evaluation of some candidate tumor markers in the diagnosis of pancreatic cancer.

Authors:  C R Mackie; A R Moossa; V L Go; G Noble; G Sizemore; M J Cooper; R A Wood; A W Hall; T Waldmann; F Gelder; A H Rubenstein
Journal:  Dig Dis Sci       Date:  1980-03       Impact factor: 3.199

10.  Hypercalcitoninaemia in patients with pheochromocytoma.

Authors:  F Raue; J M Bayer; K H Rahn; C Herfarth; H Minne; R Ziegler
Journal:  Klin Wochenschr       Date:  1978-07-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.